Literature DB >> 5410893

Plasma propranolol levels in adults with observations in four children.

D G Shand, E M Nuckolls, J A Oates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5410893     DOI: 10.1002/cpt1970111112

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  155 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

2.  Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.

Authors:  J F Giudicelli; C Richer; M Chauvin; N Idrissi; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

3.  Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

Authors:  J M Bell; C J Russell; J K Nelson; J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

4.  Proceedings: A microsomal oxidase system in rat intestinal mucosa.

Authors:  S H Curry; G P Mould
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

5.  Improved fluorimetric assay of plasma propranolol.

Authors:  L Offerhaus; J R van der Vecht
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

6.  Bioavailability of beta-adrenoceptor blocking drugs.

Authors:  G Johnsson; C G Regardh
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

7.  The distribution of propranolol between blood and plasma in hypertensive patients.

Authors:  R J Sawchuk; J Robayo; K W Miller
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

8.  Acute effects of varying doses of propranolol upon oxygen haemoglobin affinity in man.

Authors:  M C Brain; R T Card; J Kane; J Lyonnais; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

Review 9.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

10.  Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.

Authors:  T Ishizaki; K Tawara
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.